Antibody response 3 months after 2 doses of BNT162b2 mRNA COVID-19 vaccine in residents of long-term care facilities
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2022 - karger.com
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2022 - karger.com
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2021 - europepmc.org
Background Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
[HTML][HTML] Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology - ncbi.nlm.nih.gov
Background Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2022 - go.gale.com
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody response 3 months after 2 doses of BNT162b2 mRNA COVID-19 vaccine in residents of long-term care facilities.
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - 2022 - cabidigitallibrary.org
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities
R Causa, D Almagro-Nievas… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.
R Causa, D Almagro-Nievas… - …, 2022 - search.ebscohost.com
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.
R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2021 - europepmc.org
Background Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …